N-(4-氯-6-甲氧基苯基)-2,2-二甲基丙酰胺 | 113137-29-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: N-(4-氯-6-甲氧基苯基)-2,2-二甲基丙酰胺
• 英文名称: N-(4-chloro-2-methoxyphenyl)-2,2-dimethylpropanamide
• 英文别名: 4'-chloro-2'-methoxy-2,2-dimethylpropionanilide；2,2-dimethyl-N-(4-chloro-2-methoxyphenyl)propanamide
• CAS: 113137-29-4
• 化学式: C₁₂H₁₆ClNO₂
• 分子量: 241.718
• InChiKey: GGGRWOLCYDENKP-UHFFFAOYSA-N

物化性质

• 溶解度：
  可溶于氯仿、二氯甲烷、二甲基亚砜、乙酸乙酯、甲醇

计算性质

• 辛醇/水分配系数(LogP)：
  3.4
• 重原子数：
  16
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.42
• 拓扑面积：
  38.3
• 氢给体数：
  1
• 氢受体数：
  2

安全信息

• 海关编码：
  2924299090

反应信息

• 作为反应物：
  描述：

  N-(4-氯-6-甲氧基苯基)-2,2-二甲基丙酰胺 在 咪唑 、 盐酸 、 仲丁基锂 、 三溴化硼 、 N,N-二异丙基乙胺 作用下， 以 四氢呋喃 、 乙二醇二甲醚 、 正己烷 、 二氯甲烷 、 N,N-二甲基甲酰胺 、 甲苯 为溶剂， 生成 6-氯-4-(2-环丙基乙炔基)-8-[[(叔丁基)二甲基硅烷基]氧基]-1,4-二氢-4-(三氟甲基)-2H-3,1-苯并恶嗪-2-酮
  参考文献：
  名称：

  Synthesis and biological activities of potential metabolites of the non-nucleoside reverse transcriptase inhibitor Efavirenz

  摘要：

  Studies on the biotransformation of the clinically important non-nucleoside reverse transcriptase inhibitor efavirenz have shown that oxidation and secondary conjugation are important components of the processing of this molecule in vivo. We have synthesized metabolites of efavirenz to confirm their structure and to evaluate their activity as antivirals. (C) 2001 DuPont Pharmaceuticals Company. Published by Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0960-894x(01)00012-9
• 作为产物：
  描述：

  5-氯-2-硝基苯甲醚 在 乙醇 、 三乙胺 、 tin(ll) chloride 作用下， 以 二氯甲烷 为溶剂， 生成 N-(4-氯-6-甲氧基苯基)-2,2-二甲基丙酰胺
  参考文献：
  名称：

  Synthesis and biological activities of potential metabolites of the non-nucleoside reverse transcriptase inhibitor Efavirenz

  摘要：

  Studies on the biotransformation of the clinically important non-nucleoside reverse transcriptase inhibitor efavirenz have shown that oxidation and secondary conjugation are important components of the processing of this molecule in vivo. We have synthesized metabolites of efavirenz to confirm their structure and to evaluate their activity as antivirals. (C) 2001 DuPont Pharmaceuticals Company. Published by Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0960-894x(01)00012-9

文献信息

• Use of malonic acid derivative compounds for retarding plant growth
  申请人：Rhone-Poulenc Inc.

  公开号：US05292937A1

  公开（公告）日：1994-03-08

  This invention relates to a method for retarding plant growth by applying to the plant an effective amount of a malonic acid derivative compound. This invention also relates to novel malonic acid derivative compounds and processes for the preparation thereof.

  这项发明涉及一种通过向植物施加丙二酸衍生物化合物的有效量来延缓植物生长的方法。该发明还涉及新颖的丙二酸衍生物化合物及其制备方法。
• Synergistic plant growth regulator compositions
  申请人：Rhone-Poulenc Nederland B.V.

  公开号：US05123951A1

  公开（公告）日：1992-06-23

  This invention relates to synergistic plant growth regulator compositions containing (1) an ethylene response or ethylene-type response inducing agent and (11) a malonic acid derivative compound. This invention also relates to the use of said compositions for inducing synergistic plant growth regulating responses or ethylene responses or ethylene-type responses.

  这项发明涉及含有（1）乙烯响应或类似乙烯响应诱导剂和（11）丙二酸衍生物化合物的协同植物生长调节剂组合物。该发明还涉及利用上述组合物诱导协同植物生长调节响应或乙烯响应或类似乙烯响应。
• 4,4-disubstitued-1,4-dihydro-2H-3,1-benzoxazin-2-ones useful as HIV
  申请人：DuPont Pharmaceuticals Company

  公开号：US05874430A1

  公开（公告）日：1999-02-23

  The present invention relates to benzoxazinones of formula I: ##STR1## or stereoisomeric forms or mixtures, or pharmaceutically acceptable salt forms thereof, which are useful as inhibitors of HIV reverse transcriptase, and to pharmaceutical compositions and diagnostic kits comprising the same, methods of using the same for treating viral infection or as an assay standard or reagent, and intermediates and processes for making the same.

  本发明涉及式I的苯并噁唑酮：##STR1##或其立体异构体或混合物，或其药学上可接受的盐形式，其作为HIV逆转录酶抑制剂的用途，以及包含相同的药物组合物和诊断试剂盒，用于治疗病毒感染或作为测定标准或试剂的方法，以及制备相同的中间体和工艺。
• Discovery of atrop fixed alkoxy-aminobenzhydrol derivatives: Novel, highly potent and orally efficacious squalene synthase inhibitors
  作者：Masanori Ichikawa、Aki Yokomizo、Masao Itoh、Noriyasu Haginoya、Kazuyuki Sugita、Hiroyuki Usui、Koji Terayama、Akira Kanda

  DOI：10.1016/j.bmc.2011.07.007

  日期：2011.9

  template, which has a highly potent inhibitory activity for squalene synthase, as typified by compound 1 (SSI IC50 = 0.85 nM). However, it was composed of a pair of easy rotatable atropisomers. In the effort to fix the isomerization, a highly potent alkoxy-aminobenzhydrol scaffold was developed. Some of these acquired compounds demonstrating strong cholesterol synthesis inhibitory activities in a rat

  我们最近报道了发现新的苯甲醛模板的发现，该模板对角鲨烯合酶具有很强的抑制活性，如化合物1所示（SSI IC 50  = 0.85 nM）。但是，它是由一对易旋转的阻转异构体组成的。为了固定异构化，开发了高效的烷氧基-氨基苯甲酸酯支架。这些获得的化合物中的某些在大鼠肝细胞中表现出强大的胆固醇合成抑制活性。此外，这两个系列化合物在体内动物模型中显示出特定的降低血浆脂质的作用。
• 4,4-disubstituted-1, 4-dihydro-2H-3, 1-benzoxazin-2-ones useful as HIV reverse transcriptase inhibitors and intermediates and processes for making the same
  申请人：——

  公开号：US20020040138A1

  公开（公告）日：2002-04-04

  The present invention relates to benzoxazinones of formula I: 1 or stereoisomeric forms or mixtures, or pharmaceutically acceptable salt forms thereof, which are useful as inhibitors of HIV reverse transcriptase, and to pharmaceutical compositions and diagnostic kits comprising the same, methods of using the same for treating viral infection or as an assay standard or reagent, and intermediates and processes for making the same.

  本发明涉及公式I的苯并噁唑酮：1或其立体异构体或混合物，或其药学上可接受的盐形式，其用作HIV反转录酶的抑制剂，以及包含其的制药组合物和诊断试剂盒，使用其的治疗病毒感染的方法或用作检测标准或试剂，以及制造其的中间体和过程。